Marksans Pharma's Goa Facility Gets Australian TGA Approval for Exports

Marksans Pharma has stated that its pharmaceutical manufacturing unit situated at Plot A-1, Phase 1-A, Verna Industrial Estate, Goa, India, has been granted the approval from the Australian Therapeutic Goods Administration (TGA). The company to prepare pharmaceutical dosage preparation which is a solid form e.g. tablets and hard capsules for the Australian market.

The Goa-based company will use this facility to produce its pharmaceutical products. The core will be the high-quality of their products and will keep in mind that these are the products that will be recognized worldwide as having the proper approvals.

Marksans Pharma will commercially introduce to the Australian market the products approved under Nova Pharmaceuticals, a subsidiary of the company. This planned Australia extension is a means for Marksans Pharma to consequently further expand and establish the company’s local presence in the Australian pharmaceutical sector, thereby bring to the region essential medicines in a reliable manner.

Marksans Pharma is one of the largest global generic pharmaceuticals company specializing in the research, development, manufacturing, and marketing of high-quality generic medicines. With a presence in multiple countries, the company is committed to bringing the best, affordable, and effective healthcare solutions across the globe.

The company's dedication to the continued research and innovation is one of the main reasons for its growth strategy. Marksans Pharma entrusts in the most advanced technologies and research capabilities and continue day in day out to deliver solutions that are effective and affordable for people in need all over the world.

Through the TGA approval, Marksans Pharma is playing out in the field of pharmaceutical manufacturing on a high expert level and is again one of the world's trusted manufacturers of fantastic medicine.